Related Experiment Videos
Role of reovirus type 3 in persistent infantile cholestasis
Insights
Infant cholestasis may be linked to reovirus type 3 infection. Studies show higher reovirus 3 antibodies in infants with extrahepatic biliary atresia and idiopathic neonatal hepatitis, suggesting a potential cause.
Area of Science:
- Pediatrics
- Virology
- Hepatology
Background:
- Persistent infantile cholestasis is a serious condition affecting infants.
- The etiology of extrahepatic biliary atresia and idiopathic neonatal hepatitis remains unclear.
- Reovirus type 3 is a known virus with potential pathogenic roles.
Purpose of the Study:
- To investigate the association between reovirus type 3 infection and infantile cholestasis.
- To determine if reovirus type 3 antibodies are more prevalent in infants with specific cholestatic disorders.
Main Methods:
- Sera from 167 infants under 1 year were analyzed for antibodies to reovirus type 3.
- Infants were categorized into groups: extrahepatic biliary atresia, idiopathic neonatal hepatitis, other cholestatic disorders, and controls.
- Maternal sera were also studied when available.
Main Results:
- 62% of infants with extrahepatic biliary atresia and 52% with idiopathic neonatal hepatitis had reovirus 3 antibodies.
- Less than 12% of control infants or those with other cholestatic disorders showed antibodies.
- A significant correlation was observed between reovirus 3 antibodies and these two specific cholestatic conditions.
Conclusions:
- Perinatal infection with reovirus type 3 may initiate extrahepatic biliary atresia and idiopathic neonatal hepatitis.
- Reovirus type 3 is a potential etiological factor in these infantile obstructive cholangiopathies.
- Further research is warranted to confirm the causal link and explore therapeutic implications.
Abstract:
The relationship between reovirus type 3 and persistent infantile cholestasis was studied by measuring antibody to the virus in the sera of affected and control babies younger than 1 year of age. One hundred sixty-seven infants were divided into four groups: those with extrahepatic biliary atresia, idiopathic neonatal hepatitis, or other cholestatic disorders, and controls. When available, maternal sera obtained simultaneously with infant sera were also studied. The results indicate that 62% of babies with extrahepatic biliary atresia and 52% of infants with idiopathic neonatal hepatitis have reovirus 3 antibodies. In contrast, less than 12% of either normal infants or babies with other cholestatic disorders have antibodies. These observations suggest that perinatal infection with reovirus type 3 may serve as an initiating event in the genesis of two closely related forms of infantile obstructive cholangiopathy: extrahepatic biliary atresia and idiopathic neonatal hepatitis.